223 related articles for article (PubMed ID: 36635700)
21. Assessing the human health impacts of exposure to disinfection by-products--a critical review of concepts and methods.
Grellier J; Rushton L; Briggs DJ; Nieuwenhuijsen MJ
Environ Int; 2015 May; 78():61-81. PubMed ID: 25765762
[TBL] [Abstract][Full Text] [Related]
22. Exposure information in environmental health research: current opportunities and future directions for particulate matter, ozone, and toxic air pollutants.
McKone TE; Ryan PB; Ozkaynak H
J Expo Sci Environ Epidemiol; 2009 Jan; 19(1):30-44. PubMed ID: 18385670
[TBL] [Abstract][Full Text] [Related]
23. Assessing the risks of exposures to multiple chemicals with a common mechanism of toxicity: how to cumulate?
Wilkinson CF; Christoph GR; Julien E; Kelley JM; Kronenberg J; McCarthy J; Reiss R
Regul Toxicol Pharmacol; 2000 Feb; 31(1):30-43. PubMed ID: 10715222
[TBL] [Abstract][Full Text] [Related]
24. Applying community resilience theory to engagement with residents facing cumulative environmental exposure risks: lessons from Louisiana's industrial corridor.
Reams MA; Irving JK
Rev Environ Health; 2019 Sep; 34(3):235-244. PubMed ID: 31473690
[TBL] [Abstract][Full Text] [Related]
25. The EPA's human exposure research program for assessing cumulative risk in communities.
Zartarian VG; Schultz BD
J Expo Sci Environ Epidemiol; 2010 Jun; 20(4):351-8. PubMed ID: 19367326
[TBL] [Abstract][Full Text] [Related]
26. Advancing internal exposure and physiologically-based toxicokinetic modeling for 21st-century risk assessments.
Cohen Hubal EA; Wetmore BA; Wambaugh JF; El-Masri H; Sobus JR; Bahadori T
J Expo Sci Environ Epidemiol; 2019 Jan; 29(1):11-20. PubMed ID: 30116055
[TBL] [Abstract][Full Text] [Related]
27. The implementation of medical monitoring programs following potentially hazardous exposures: a medico-legal perspective.
Vearrier D; Greenberg MI
Clin Toxicol (Phila); 2017 Nov; 55(9):956-969. PubMed ID: 28644057
[TBL] [Abstract][Full Text] [Related]
28. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
29. Human biomonitoring as a pragmatic tool to support health risk management of chemicals--examples under the EU REACH programme.
Boogaard PJ; Hays SM; Aylward LL
Regul Toxicol Pharmacol; 2011 Feb; 59(1):125-32. PubMed ID: 20933039
[TBL] [Abstract][Full Text] [Related]
30. The impact of new technologies on human population studies.
Waters MD; Selkirk JK; Olden K
Mutat Res; 2003 Nov; 544(2-3):349-60. PubMed ID: 14644337
[TBL] [Abstract][Full Text] [Related]
31. Effect thresholds and 'adequate control' of risks: The fatal flaws in the EU council's position on authorisation within REACH.
Santillo D; Johnston P
Environ Sci Pollut Res Int; 2006 Oct; 13(6):425-31. PubMed ID: 17120834
[TBL] [Abstract][Full Text] [Related]
32. Realist review of policy intervention studies aimed at reducing exposures to environmental hazards in the United States.
Apollonio DE; Wolfe N; Bero LA
BMC Public Health; 2016 Aug; 16(1):822. PubMed ID: 27539238
[TBL] [Abstract][Full Text] [Related]
33. Understanding population and individual risk assessment: the case of polychlorinated biphenyls.
Shields PG
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):830-9. PubMed ID: 16702358
[TBL] [Abstract][Full Text] [Related]
34. Human biomonitoring in health risk assessment in Europe: Current practices and recommendations for the future.
Louro H; Heinälä M; Bessems J; Buekers J; Vermeire T; Woutersen M; van Engelen J; Borges T; Rousselle C; Ougier E; Alvito P; Martins C; Assunção R; Silva MJ; Pronk A; Schaddelee-Scholten B; Del Carmen Gonzalez M; de Alba M; Castaño A; Viegas S; Humar-Juric T; Kononenko L; Lampen A; Vinggaard AM; Schoeters G; Kolossa-Gehring M; Santonen T
Int J Hyg Environ Health; 2019 Jun; 222(5):727-737. PubMed ID: 31176761
[TBL] [Abstract][Full Text] [Related]
35. Integrated testing and intelligent assessment-new challenges under REACH.
Ahlers J; Stock F; Werschkun B
Environ Sci Pollut Res Int; 2008 Oct; 15(7):565-72. PubMed ID: 18818964
[TBL] [Abstract][Full Text] [Related]
36. Nurses' role in children's environmental health protection.
Sattler B; Davis del BA
Pediatr Nurs; 2008; 34(4):329-39. PubMed ID: 18814568
[TBL] [Abstract][Full Text] [Related]
37. Project TENDR.
Anderko L
Am J Nurs; 2017 May; 117(5):61-64. PubMed ID: 28448366
[TBL] [Abstract][Full Text] [Related]
38. Children's health and the environment: public health issues and challenges for risk assessment.
Landrigan PJ; Kimmel CA; Correa A; Eskenazi B
Environ Health Perspect; 2004 Feb; 112(2):257-65. PubMed ID: 14754581
[TBL] [Abstract][Full Text] [Related]
39. Informing 21st-Century Risk Assessments with 21st-Century Science.
Birnbaum LS; Burke TA; Jones JJ
Environ Health Perspect; 2016 Apr; 124(4):A60-3. PubMed ID: 27035154
[TBL] [Abstract][Full Text] [Related]
40. Do Interactions Between Environmental Chemicals and the Human Microbiome Need to Be Considered in Risk Assessments?
Rodricks J; Huang Y; Mantus E; Shubat P
Risk Anal; 2019 Nov; 39(11):2353-2358. PubMed ID: 31070803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
